Alectinib(艾乐替尼) is an orally available inhibitor of the receptor tyrosine kinase anaplastic lymphoma kinase (ALK) with antineoplastic activity.
Lenvatinib mesylate(乐伐替尼甲磺酸盐) is a synthetic, orally available inhibitor of VEGFR2 tyrosine kinase with potential antineoplastic activity.
Gefitinib hydrochloride(吉非替尼盐酸盐) is a selective tyrosine kinase receptor inhibitor.
Apatinib mesylate(甲磺酸阿帕替尼) is an orally bioavailable, selective VEGFR2 inhibitor.
Regorafenib(瑞格非尼) is an oral multi-kinase inhibitor, and Cytochrome P450 2C9 Inhibitor.
Pazopanib(帕唑帕尼) is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity.
Pazopanib hydrochloride(盐酸帕唑帕尼) is a small molecule inhibitor of multiple protein tyrosine kinases with potential antineoplastic activity.
Poziotinib (HM781-36B) is an irreversible pan-HER inhibitor.